Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
复制标题
对 Rhodes 等人的《万古霉素治疗大鼠急性肾损伤新型尿液生物标志物升高相关万古霉素暴露的评估》进行修正。
DOI:
10.1128/aac.00185-17
复制
发表时间:
2017
影响因子:
4.9
通讯作者:
Scheetz,MarcH
中科院分区:
文献类型:
--
作者:
Rhodes,NathanielJ;Prozialeck,WalterC;Lodise,ThomasP;Venkatesan,Natarajan;O'Donnell,JNicholas;Pais,Gwendolyn;Cluff,Cameron;Lamar,PeterC;Neely,MichaelN;Gulati,Anil;Scheetz,MarcH
Volume 60, no. 10, p. 5742–5751, 2016. A dilution factor correction was not used for our reported protein biomarkers. This correction factor for dilution is 2-fold for kidney injury molecule 1 (KIM-1), clusterin, and osteopontin and 500-fold for neutrophil gelatinase-associated lipocalin 2 and cystatin C. Thus, all reported point estimates for KIM-1, clusterin, and osteopontin should be doubled, and those for neutrophil gelatinase-associated lipocalin 2 and cystatin C should be multiplied by 500. The multiplicative differences do not affect any of the inferential statistics. All P values were isometric on recalculation. Therefore, the interpretation and conclusions of the manuscript remain the same.